{"filing":{"accession_number":"0001096906-26-001602","cik":"0000706698","ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-22","primary_document":"utmd-20261022_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690626001602/utmd-20261022_8k.htm"},"events":[{"id":37164,"run_id":34264,"accession_number":"0001096906-26-001602","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Utah Medical Products disclosed third quarter and nine-month 2026 financial results on October 22, 2026, including detailed revenue, gross profit, operating income, net income, and earnings per share comparisons to prior-year periods, along with forward-looking guidance for full-year 2026 sales expectations.","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":[{"id":41782,"accession_number":"0001096906-26-001602","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing UTMD's third quarter and nine-month 2026 financial results, including detailed revenue, gross profit, operating income, and net income comparisons to prior-year periods. The press release dated October 22, 2026 is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes comprehensive financial statements and forward-looking guidance for full-year 2026 sales expectations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T19:11:41.188519+00:00","company_name":"","ticker":null,"filing_date":""},{"id":41783,"accession_number":"0001096906-26-001602","item_number":"99.1","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release dated October 22, 2026, disclosing Utah Medical Products' third quarter and nine-month 2026 financial results, including revenues, gross profit, operating income, net income, and earnings per share comparisons to prior-year periods. The filing includes detailed financial statements and forward-looking guidance for full-year 2026 sales expectations, which are core components of an earnings release disclosure under Item 2.02 (or in this case Item 99.1, which appears to be a supplemental disclosure vehicle).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T19:11:41.188519+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41782,"accession_number":"0001096906-26-001602","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing UTMD's third quarter and nine-month 2026 financial results, including detailed revenue, gross profit, operating income, and net income comparisons to prior-year periods. The press release dated October 22, 2026 is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes comprehensive financial statements and forward-looking guidance for full-year 2026 sales expectations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T19:11:41.188519+00:00","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-10-22"},{"id":41783,"accession_number":"0001096906-26-001602","item_number":"99.1","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release dated October 22, 2026, disclosing Utah Medical Products' third quarter and nine-month 2026 financial results, including revenues, gross profit, operating income, net income, and earnings per share comparisons to prior-year periods. The filing includes detailed financial statements and forward-looking guidance for full-year 2026 sales expectations, which are core components of an earnings release disclosure under Item 2.02 (or in this case Item 99.1, which appears to be a supplemental disclosure vehicle).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T19:11:41.188519+00:00","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-10-22"}]}